-
Zocor Label Change: Interstitial Lung Disease (ILD) Added As Possible Adverse Reaction
November 2010 FDA Approval Of Merck Action Raises Profile Of This Emerging Drug Safety Issue (Posted by Tom Lamb at DrugInjuryWatch.com) As we reported recently, the October 2010 issue of the Canadian Adverse Reaction…
-
Sprint Fidelis Lead Wire Defect Litigation Comes To An Apparent Disappointing End (Medtronic Wins)
8100 Pending Lawsuits Get Modest Settlement Payments; Remaining 100,000 Plus U.S. Patients Have No Legal Claim Due To Federal Preemption Ruling (Posted by Tom Lamb at DrugInjuryWatch.com) As those who have been following the Sprint…
-
Health Canada And FDA Issue Adverse Reaction Updates In Second Half Of 2010 Which Involve Popular Drug Zocor (Simvastatin)
Cases Of Interstitial Lung Disease (ILD) And Rhabdomyolysis / Myopathy Associated With Cholesterol Drugs Known As Statins, Including Zocor (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: FDA Drug Safety Communication: New restrictions, contraindications,…
-
Osteoporosis Medication Aclasta Associated With Renal Impairment And Kidney Failure
Novartis Sends "Dear Doctor" Letter To Canadian Physicians With Health Canada Endorsed Safety Information (Posted by Tom Lamb at DrugInjuryWatch.com) In 2007 Aclasta (zoledronic acid 5mg) was approved by the FDA under the brand name Aclasta®…
-
YAZ And Yasmin MDL: First Trial In Federal Court Set By Judge Herndon To Start September 2011
A Pulmonary Embolism Bellwether Case Will Be Followed By Gallbladder And Venous Thromboembolic Lawsuit Trials (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: The January 9, 2012 Sims v. Bayer "bellwether", or test, trial has been postponed…
